TWD
RAPP icon

True Wealth Design’s Rapport Therapeutics RAPP Stock Holding History

True Wealth Design’s Portfolio RAPP Stock Details RAPP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.38K Hold
41
– – ﹤0.01% 1820
2026
Q2 		$1.71K Sell
41
-3
-7% -$110 ﹤0.01% 1757
2026
Q1 		$1.38K Hold
44
– – ﹤0.01% 1687
2025
Q4 		$1.33K Hold
44
– – ﹤0.01% 1601
2025
Q3 		$1.31K Hold
44
– – ﹤0.01% 1656
2025
Q2 		$501 Buy
44
+41
+1,367% +$435 ﹤0.01% 1745
2025
Q1 		$31 Buy
+3
New +$39 ﹤0.01% 2511

Other funds holding RAPP

CPW
Catalyst Private Wealth San Mateo, California $239M AUM 21.76% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
MassMutual Private Wealth & Trust
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

True Wealth Design's RAPP Position: Q3 2026 in Review

True Wealth Design held its Rapport Therapeutics (RAPP) position steady in Q3 2026 at 41 shares worth $1.38K. The position accounts for ﹤0.01% of the portfolio, ranked #1820.

True Wealth Design first reported a position in RAPP in Q1 2025 and has held it in 7 quarters since. The position peaked at $1.71K in Q2 2026. 8 funds tracked by Wall St. Rank hold RAPP as of Q3 2026.

  • True Wealth Design held 41 shares of Rapport Therapeutics worth $1.38K as of Q3 2026.
  • True Wealth Design left its Rapport Therapeutics share count unchanged in Q3 2026.
  • Rapport Therapeutics made up ﹤0.01% of True Wealth Design's portfolio in Q3 2026, its #1820 holding.
  • True Wealth Design first reported a position in Rapport Therapeutics in Q1 2025 and has held it in 7 quarters since.
  • True Wealth Design's Rapport Therapeutics position peaked at $1.71K in Q2 2026.
  • 8 funds tracked by Wall St. Rank held Rapport Therapeutics as of Q3 2026.

Based on True Wealth Design's 13F filing for Q3 2026, filed 13 Oct 2026.